Nuclear Medicine and Radiopharmaceutic Market Report

Global and Region Nuclear Medicine and Radiopharmaceutic Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：164
  • REPORT CODE：GMM946833
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nuclear Medicine and Radiopharmaceutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nuclear Medicine and Radiopharmaceuticmarket, defines the market attractiveness level of Nuclear Medicine and Radiopharmaceutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nuclear Medicine and Radiopharmaceutic industry, describes the types of Nuclear Medicine and Radiopharmaceutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nuclear Medicine and Radiopharmaceutic market and the development prospects and opportunities of Nuclear Medicine and Radiopharmaceutic industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nuclear Medicine and Radiopharmaceutic market in Chapter 13.

    By Player:

    • Navidea?

    • SIEMENS?

    • Bayer?

    • Mallinckrodt?

    • IBA Group?

    • GE Healthcare?

    • Triad Isotopes?

    • Bracco Imaging?

    • Company?

    • Advanced Accelerator Applications?

    • Dongcheng?

    • Eli Lilly?

    • Lantheus?

    • China Isotope & Radiation?

    • Jubilant Pharma?

    • Nordion?

    By Type:

    • Diagnostic Radioisotopes?

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology?

    • Cardiology?

    • Others?

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nuclear Medicine and Radiopharmaceutic Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nuclear Medicine and Radiopharmaceutic Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nuclear Medicine and Radiopharmaceutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nuclear Medicine and Radiopharmaceutic Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nuclear Medicine and Radiopharmaceutic Market Analysis and Outlook to 2022

    • 7.1 Global Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.2 United States Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.3 Europe Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.4 China Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.5 Japan Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.6 India Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    • 7.7 South Korea Nuclear Medicine and Radiopharmaceutic Consumption (2017-2022)

    8 Region and Country-wise Nuclear Medicine and Radiopharmaceutic Market Analysis and Outlook to 2028

    • 8.1 Global Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.2 United States Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.3 Europe Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.4 China Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.5 Japan Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.6 India Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    • 8.7 South Korea Nuclear Medicine and Radiopharmaceutic Consumption Forecast (2022-2028)

    9 Global Nuclear Medicine and Radiopharmaceutic Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Diagnostic Radioisotopes? Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology? Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology? Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others? Consumption and Growth Rate (2017-2022)

    10 Global Nuclear Medicine and Radiopharmaceutic Market Outlook by Types and Applications to 2028

    • 10.1 Global Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Diagnostic Radioisotopes? Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology? Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiology? Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others? Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nuclear Medicine and Radiopharmaceutic Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nuclear Medicine and Radiopharmaceutic Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nuclear Medicine and Radiopharmaceutic Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nuclear Medicine and Radiopharmaceutic Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nuclear Medicine and Radiopharmaceutic Market Competitive Analysis

    • 14.1 Navidea?

      • 14.1.1 Navidea? Company Details

      • 14.1.2 Navidea? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Navidea? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.2 SIEMENS?

      • 14.2.1 SIEMENS? Company Details

      • 14.2.2 SIEMENS? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 SIEMENS? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.3 Bayer?

      • 14.3.1 Bayer? Company Details

      • 14.3.2 Bayer? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.4 Mallinckrodt?

      • 14.4.1 Mallinckrodt? Company Details

      • 14.4.2 Mallinckrodt? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Mallinckrodt? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.5 IBA Group?

      • 14.5.1 IBA Group? Company Details

      • 14.5.2 IBA Group? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 IBA Group? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.6 GE Healthcare?

      • 14.6.1 GE Healthcare? Company Details

      • 14.6.2 GE Healthcare? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GE Healthcare? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.7 Triad Isotopes?

      • 14.7.1 Triad Isotopes? Company Details

      • 14.7.2 Triad Isotopes? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Triad Isotopes? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.8 Bracco Imaging?

      • 14.8.1 Bracco Imaging? Company Details

      • 14.8.2 Bracco Imaging? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bracco Imaging? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.9 Company?

      • 14.9.1 Company? Company Details

      • 14.9.2 Company? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Company? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.10 Advanced Accelerator Applications?

      • 14.10.1 Advanced Accelerator Applications? Company Details

      • 14.10.2 Advanced Accelerator Applications? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Advanced Accelerator Applications? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.11 Dongcheng?

      • 14.11.1 Dongcheng? Company Details

      • 14.11.2 Dongcheng? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Dongcheng? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.12 Eli Lilly?

      • 14.12.1 Eli Lilly? Company Details

      • 14.12.2 Eli Lilly? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Eli Lilly? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.13 Lantheus?

      • 14.13.1 Lantheus? Company Details

      • 14.13.2 Lantheus? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Lantheus? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.14 China Isotope & Radiation?

      • 14.14.1 China Isotope & Radiation? Company Details

      • 14.14.2 China Isotope & Radiation? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 China Isotope & Radiation? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.15 Jubilant Pharma?

      • 14.15.1 Jubilant Pharma? Company Details

      • 14.15.2 Jubilant Pharma? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Jubilant Pharma? Nuclear Medicine and Radiopharmaceutic Product and Service

    • 14.16 Nordion?

      • 14.16.1 Nordion? Company Details

      • 14.16.2 Nordion? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Nordion? Nuclear Medicine and Radiopharmaceutic Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nuclear Medicine and Radiopharmaceutic

    • Figure Nuclear Medicine and Radiopharmaceutic Picture

    • Table Global Nuclear Medicine and Radiopharmaceutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine and Radiopharmaceutic Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nuclear Medicine and Radiopharmaceutic Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nuclear Medicine and Radiopharmaceutic Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure China Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine and Radiopharmaceutic Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine and Radiopharmaceutic Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine and Radiopharmaceutic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Radioisotopes? Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology? Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology? Consumption and Growth Rate (2017-2022)

    • Figure Global Others? Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Radioisotopes? Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology? Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology? Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others? Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nuclear Medicine and Radiopharmaceutic Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nuclear Medicine and Radiopharmaceutic Export by Region (Top 5 Countries) (2017-2028)

    • Table Navidea? (Foundation Year, Company Profile and etc.)

    • Table Navidea? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navidea? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table SIEMENS? (Foundation Year, Company Profile and etc.)

    • Table SIEMENS? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIEMENS? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Bayer? (Foundation Year, Company Profile and etc.)

    • Table Bayer? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Mallinckrodt? (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table IBA Group? (Foundation Year, Company Profile and etc.)

    • Table IBA Group? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Group? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table GE Healthcare? (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Triad Isotopes? (Foundation Year, Company Profile and etc.)

    • Table Triad Isotopes? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Triad Isotopes? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Bracco Imaging? (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Company? (Foundation Year, Company Profile and etc.)

    • Table Company? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Advanced Accelerator Applications? (Foundation Year, Company Profile and etc.)

    • Table Advanced Accelerator Applications? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Dongcheng? (Foundation Year, Company Profile and etc.)

    • Table Dongcheng? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Eli Lilly? (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Lantheus? (Foundation Year, Company Profile and etc.)

    • Table Lantheus? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table China Isotope & Radiation? (Foundation Year, Company Profile and etc.)

    • Table China Isotope & Radiation? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope & Radiation? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Jubilant Pharma? (Foundation Year, Company Profile and etc.)

    • Table Jubilant Pharma? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharma? Nuclear Medicine and Radiopharmaceutic Product and Service

    • Table Nordion? (Foundation Year, Company Profile and etc.)

    • Table Nordion? Nuclear Medicine and Radiopharmaceutic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion? Nuclear Medicine and Radiopharmaceutic Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US